Abstract |
Inhibin is an ovarian protein previously shown, using a nonspecific assay, to be elevated in serum of women with ovarian cancer. However, inhibin is secreted in multiple biochemical forms, including dimeric inhibin A and B and alpha inhibin precursors (pro-alphaC), each of which can now be specifically measured. We have examined the secretion of inhibin B and pro-alphaC inhibin in serum from women with epithelial ovarian cancer (EOC) for the first time, and have compared these analytes to inhibin A and total inhibin ( inhibin A + B + pro-alphaC) as potential serum markers for EOC in postmenopausal women. Of all the immunoreactive inhibin proteins studied, the best serum marker was pro-alphaC, with 22% of women with EOC having levels that exceeded the range of values in women without EOC. Since CA 125 and pro-alphaC levels were not significantly correlated, combination of these markers resulted in 87% of EOC cases having elevated preoperative serum levels, a 9% increase over CA 125 alone. These data suggest that alpha inhibin secretion, especially pro-alphaC, may be useful in addition to CA 125 as a serum marker for EOC in postmenopausal women.
|
Authors | G M Lambert-Messerlian, M Steinhoff, W Zheng, J A Canick, W H Gajewski, D B Seifer, A L Schneyer |
Journal | Gynecologic oncology
(Gynecol Oncol)
Vol. 65
Issue 3
Pg. 512-6
(Jun 1997)
ISSN: 0090-8258 [Print] United States |
PMID | 9190984
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Aged
- Aged, 80 and over
- Female
- Humans
- Inhibins
(blood)
- Middle Aged
- Ovarian Neoplasms
(blood)
- Postmenopause
|